Memory-like differentiation enhances NK cell responses against colorectal cancer
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - May 7, 2024 Category: Cancer & Oncology Authors: Nancy D. MarinMichelle Becker-HapakWilbur M. SongQuazim A. AlayoLynne MarsalaNaomi SonnekMelissa M. Berrien-ElliottMark FosterJennifer A. FoltzJennifer TranPamela WongCelia C. CubittPatrick PenceKimberly HwangAlice Y. ZhouMiriam T. JacobsTimothy SchappeDa Source Type: research
Principles of risk assessment in colon cancer: immunity is key
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - April 30, 2024 Category: Cancer & Oncology Authors: Assia HijaziJ érôme Galona INSERM, Laboratory of Integrative Cancer Immunology, Paris, Franceb Equipe Labellisée Ligue Contre le Cancer, Paris, Francec Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Paris, Franced Ve Source Type: research
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - April 26, 2024 Category: Cancer & Oncology Authors: Joel KidmanRachael M. ZemekJohn-William SidhomDebora CorreaNicola PrincipeFezaan SheikhVanessa S. FearCatherine A. ForbesAbha ChopraLouis BoonAyham ZaitounyEmma de JongRobert A. HoltMatt JonesMichael J. MillwardTimo LassmannAlistair R.R. ForrestAnna K. No Source Type: research
The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - April 23, 2024 Category: Cancer & Oncology Authors: Yuwen ChenJie GaoMingyue MaKe WangFangming LiuFeiyu YangXin ZouZhouli ChengDuojiao Wua Jinshan Hospital Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, Chinab Shanghai Key Laboratory of Lung Inflammation and Injury, Zh Source Type: research
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF- β and PD-L1 enhances antitumor responses
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - April 13, 2024 Category: Cancer & Oncology Authors: Antonio Tapia-GalisteoI ñigo Sánchez-RodríguezJavier NarbonaPatricia Iglesias-HernándezSaray Aragón-GarcíaAnaïs Jiménez-ReinosoMarta CompteShaukat KhanTakeshi TsudaPatrick ChamesJavier LacadenaLuis Álvarez-VallinaLaura Sanza Molecular Immunology Source Type: research
Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - April 9, 2024 Category: Cancer & Oncology Authors: Xue-Wu WeiChang LuYi-Chen ZhangXue FanChong-Rui XuZhi-Hong ChenFen WangXiao-Rong YangJia-Yi DengMing-Yi YangQing GouShi-Qi MeiWei-Chi LuoRi-Wei ZhongWen-Zhao ZhongJin-Ji YangXu-Chao ZhangHai-Yan TuYi-Long WuQing Zhoua School of Medicine, South China Unive Source Type: research
PD-L1+ macrophages suppress T cell-mediated anticancer immunity
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - April 5, 2024 Category: Cancer & Oncology Authors: Peng LiuLiwei ZhaoGuido KroemerOliver Keppa Centre de Recherche des Cordeliers, Equipe Labellis ée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, Franceb Metabolomics and Cell Bio Source Type: research
CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - April 5, 2024 Category: Cancer & Oncology Authors: Ayush PantBrandon Hwa-Lin BergsneiderSiddhartha SrivastavaTimothy KimAanchal JainSadhana BomPavan ShahNivedha KannapadiKisha PatelJohn ChoiKwang Bog ChoRohit VermaCaren Yu-Ju WuHenry BremBetty TylerDrew M. PardollChristina JacksonMichael Lima Department o Source Type: research
Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - March 20, 2024 Category: Cancer & Oncology Authors: Min MaLiang LiShu-Han YangChuan HuangWeitao ZhuangShujie HuangXin XiaYong TangZijun LiZhi-Bin ZhaoQingyun ChenGuibin QiaoZhe-Xiong Liana Chronic Disease Laboratory, School of Medicine South China University of Technology, Guangzhou, Chinab Guangdong Provi Source Type: research
STING is significantly increased in high-grade glioma with high risk of recurrence
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - March 20, 2024 Category: Cancer & Oncology Authors: Meishi ZhongManmei LongChenjie HanSaiyan JiQingyuan YangDepartment of Pathology, Shanghai Ninth People ’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Source Type: research
Co-inhibition of TGF- β and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - March 20, 2024 Category: Cancer & Oncology Authors: Reshmi NairTamsin R. M. LannaganRene JackstadtAnna AndrusaiteJohn ColeCaitlin BoyneRobert J. B. NibbsOwen J. SansomSimon Millinga School of infection and immunity, University of Glasgow, Glasgow, UKb Cancer Research UK Scotland Institute, Glasgow, UKc Sch Source Type: research
Trial watch: local anesthetics in cancer therapy
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - March 18, 2024 Category: Cancer & Oncology Authors: Killian Carnet Le ProvostOliver KeppGuido KroemerLucillia Bezua Equipe Labellis ée Par La Ligue Contre Le Cancer, Université de Paris, Sorbonne Université, Centre de Recherche des Cordeliers, Institut Universitaire de France, Paris, Franceb Metabolomic Source Type: research
Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - March 15, 2024 Category: Cancer & Oncology Authors: Vikram S. PothuriGraham D. HoggLeah ConantNicholas BorcherdingC. Alston JamesJacqueline MuddGreg WilliamsYongwoo David SeoWilliam G. HawkinsVenu G. PillarisettyDavid G. DeNardoRyan C. Fieldsa Department of Surgery, Washington University School of Medicine Source Type: research
Humoral complementomics – exploration of noninvasive complement biomarkers as predictors of renal cancer progression
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - March 13, 2024 Category: Cancer & Oncology Authors: Margot RevelMikel Rezola ArteroHoucine HamidiAnne GrunenwaldLoris BlascoYann A. VanoStephane Marie OudardRafael Sanchez-SalasPetr MacekLara Rodriguez SanchezXavier CathelineauBenoit Vedi éCatherine Sautes-FridmanWolf Herman FridmanLubka T. RoumeninaMarie Source Type: research
Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer
Volume 13, Issue 1, December 2024 . (Source: OncoImmunology)
Source: OncoImmunology - March 12, 2024 Category: Cancer & Oncology Authors: Erin M. DickeyAnna BianchiHaleh AmirianPeter J. HoseinDenise FaustmanRoberta BrambillaJashodeep Dattaa Division of Surgical Oncology, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USAb Department of Medic Source Type: research
